What are the effects of volatile anesthetic agents (sevoflurane, isoflurane, desflurane) on vital signs such as blood pressure, heart rate, respiratory drive, temperature, and intracranial pressure?

Effects of Volatile Anesthetic Agents on Vital Signs

All volatile anesthetic agents (sevoflurane, isoflurane, desflurane) cause dose-dependent myocardial depression and afterload reduction, with desflurane uniquely causing transient hypertension and tachycardia during rapid concentration increases, particularly problematic during induction. 1, 2

Cardiovascular Effects

Blood Pressure

All three agents produce dose-dependent decreases in mean arterial pressure through two mechanisms: direct myocardial contractility depression and systemic vascular resistance reduction 1, 3, 4. The similarities between agents are greater than their differences in terms of blood pressure effects during maintenance 1.

However, desflurane is distinct during induction and rapid concentration increases—it causes transient increases in heart rate, arterial pressure, and pulmonary blood pressure when concentration rises rapidly 4, 5. This sympathetic surge can be clinically significant: in one study, desflurane induction without opioids caused new transient ischemia in 14 cardiac patients versus 0 with sufentanil 4.

Sevoflurane maintains better hemodynamic stability during induction compared to isoflurane and desflurane 6, 5. At 2.0 MAC, sevoflurane maintains higher cerebral perfusion pressure and systolic/diastolic blood pressures compared to equipotent isoflurane 7.

Heart Rate

• Isoflurane: Produces sustained tachycardia at concentrations ≥1.8 MAC, with peak increases of 15-17 bpm 5. Heart rate after surgical incision is faster with isoflurane than sevoflurane 6
• Sevoflurane: Does not produce increases in heart rate at doses <2 MAC 3. Maintains more stable heart rate during induction and maintenance 6, 5
• Desflurane: Causes marked tachycardia during rapid concentration increases, particularly at airway irritating concentrations 8, 4, 5. Can induce increased airway resistance along with hypertension and tachycardia 8

Clinical Implications for Cardiac Patients

For patients with coronary artery disease, desflurane should never be used as the sole induction agent 4. If used, it must be combined with intravenous opioids and hypnotics to prevent dangerous hemodynamic responses. The ACC/AHA guidelines note that volatile anesthetics can be beneficial for maintenance in hemodynamically stable patients at risk for myocardial ischemia, showing cardioprotective effects with decreased troponin release and enhanced left ventricular function 1, 2.

Respiratory Effects

Respiratory Drive

All volatile agents depress respiratory drive in a dose-dependent manner. Desflurane produces the highest incidence of respiratory irritation during mask induction: coughing, breath-holding, apnea, increased secretions, and laryngospasm 4. Oxyhemoglobin saturation below 90% occurred in 6-7% of adult patients during desflurane induction 4.

Sevoflurane has bronchodilator effects, making it preferable in patients with reactive airway disease 8. Desflurane, conversely, can induce increased airway resistance 8.

Practical Consideration

The decision regarding which inhalational agent to use should be determined based on existing comorbidities: use sevoflurane for patients with asthma or COPD; avoid desflurane for mask induction or in patients where airway irritation is problematic 8.

Intracranial Pressure

The evidence on ICP effects is conflicting and requires careful interpretation:

• In healthy normocapnic dogs, mean ICP did not differ between sevoflurane and isoflurane at any MAC level, though sevoflurane maintained better cerebral perfusion pressure at 2.0 MAC 7
• However, in rats with diffuse brain injury, sevoflurane produced significantly higher ICP and lower cerebral perfusion pressure compared to isoflurane 9. ICP increased significantly at 45 minutes with sevoflurane and remained elevated throughout the study period

Clinical recommendation: In patients with traumatic brain injury or at risk for increased intracranial pressure, isoflurane, sevoflurane, and desflurane are weakly recommended over propofol for maintenance, except in patients at risk of increased ICP where this recommendation is reversed 10. The evidence suggests greater caution with sevoflurane in the setting of existing brain injury.

Temperature Effects

All volatile agents can trigger malignant hyperthermia in susceptible patients (those with RYR1 or CACNA1S variants) 11, 3. The most crucial recommendation is that malignant hyperthermia-susceptible patients should receive anesthesia completely free of triggering agents—this means avoiding all volatile anesthetics (sevoflurane, isoflurane, desflurane) entirely 11.

Core body temperature should be monitored during volatile anesthetic administration, though the agents themselves do not directly cause hypothermia beyond normal anesthetic-induced thermoregulatory impairment.

Agent-Specific Dosing Considerations

Bariatric Patients

Anesthesia induction should be based on lean body weight to avoid hypotension, while total body weight may be more appropriate for maintenance infusion 8. Desflurane offers faster wake-up times compared to sevoflurane or isoflurane in patients with BMI ≥30 kg/m² 8.

Hepatic Dysfunction

Isoflurane, sevoflurane, and desflurane are weakly recommended over propofol for maintenance of anesthesia in patients with cirrhosis due to their low hepatic metabolism 10. However, this recommendation is reversed in patients at risk of increased intracranial pressure (relevant in hepatic encephalopathy).

Common Pitfalls to Avoid

1. Never use desflurane for mask induction or as a sole agent in cardiac patients—the sympathetic surge and airway irritation are predictable and dangerous 4, 5

2. Don't assume ICP effects are benign—while healthy patients tolerate volatile agents well, those with existing brain injury may experience significant ICP elevations, particularly with sevoflurane 9

3. Avoid rapid concentration increases with desflurane—the tachycardia and hypertension are concentration-rate dependent, not just concentration-dependent 4, 5

4. Don't forget cardioprotective benefits—despite hemodynamic effects, volatile anesthetics show preconditioning effects with decreased troponin release and improved outcomes in cardiac surgery patients 1, 2, 12